menu search

Pharmaxis discoveries to get a a$1.4 million boost to advance cancer and skin disease treatments

Pharmaxis Ltd's drug discoveries have been given a boost after the Australian government awarded two grants totalling A$1.4 million to respected scie...

January 6, 2022, 12:21 am

Pharmaxis discoveries to get a a$1.4 million boost to advance cancer and skin disease treatments

Pharmaxis Ltd's drug discoveries have been given a boost after the Australian government awarded two grants totalling A$1.4 million to respected scie...

January 6, 2022, 12:21 am

Pharmaxis discoveries to get a $1.4m boost to advance cancer and skin disease treatments

Pharmaxis Ltd's drug discoveries have been given a boost after the Australian government awarded two grants totalling $1.4 million to respected scien...

January 6, 2022, 12:15 am

Pharmaxis discoveries to get a $1.4m boost to advance cancer and skin disease treatments

Pharmaxis Ltd's drug discoveries have been given a boost after the Australian government awarded two grants totalling $1.4 million to respected scien...

January 6, 2022, 12:15 am

Pharmaxis discoveries to get a $1.4m boost to advance cancer and skin disease treatments

Pharmaxis Ltd's drug discoveries have been given a boost after the Australian government awarded two grants totalling $1.4 million to respected scien...

January 6, 2022, 12:15 am

4 oil & gas stocks that more than doubled in 2021

With several vaccines and treatments in hand to combat coronavirus, fuel demand has improved dramatical...

December 31, 2021, 1:00 pm

4 oil & gas stocks that more than doubled in 2021

With several vaccines and treatments in hand to combat coronavirus, fuel demand has improved dramatical...

December 31, 2021, 1:00 pm

4 oil & gas stocks that more than doubled in 2021

With several vaccines and treatments in hand to combat coronavirus, fuel demand has improved dramatical...

December 31, 2021, 1:00 pm

Merck's (mrk) covid pill gets fda nod for emergency use

Merck's (MRK) oral antiviral molnupiravir secures the FDA-authorized emergency use tag in treating mild-to-moderate COVID-19 in adults for whom other ...

December 24, 2021, 1:48 pm

Merck's (mrk) covid pill gets fda nod for emergency use

Merck's (MRK) oral antiviral molnupiravir secures the FDA-authorized emergency use tag in treating mild-to-moderate COVID-19 in adults for whom other ...

December 24, 2021, 1:48 pm

Merck's (mrk) covid pill gets fda nod for emergency use

Merck's (MRK) oral antiviral molnupiravir secures the FDA-authorized emergency use tag in treating mild-to-moderate COVID-19 in adults for whom other ...

December 24, 2021, 1:48 pm

Imugene secures fda approval for two clinical trials of promising oncology drug candidates

Imugene Limited (ASX:IMU, OTC:IUGNF) has obtained US Food and Drug Administration (FDA) consent for clinical trials for two of its oncology ...

December 12, 2021, 7:40 pm

Imugene secures fda approval for two clinical trials of promising oncology drug candidates

Imugene Limited (ASX:IMU, OTC:IUGNF) has obtained US Food and Drug Administration (FDA) consent for clinical trials for two of its oncology ...

December 12, 2021, 7:40 pm

Imugene secures fda approval for two clinical trials of promising oncology drug candidates

Imugene Limited (ASX:IMU, OTC:IUGNF) has obtained US Food and Drug Administration (FDA) consent for clinical trials for two of its oncology ...

December 12, 2021, 7:40 pm

Akero therapeutics to present at the evercore isi 4th annual healthconx virtual conference

SOUTH SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational...

November 26, 2021, 5:28 pm

Akero therapeutics to present at the evercore isi 4th annual healthconx virtual conference

SOUTH SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational...

November 26, 2021, 5:28 pm

Akero therapeutics to present at the evercore isi 4th annual healthconx virtual conference

SOUTH SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational...

November 26, 2021, 5:28 pm

Journey medical aims for $35 million ipo

Journey Medical Corporation has filed proposed terms for a $35.2 million IPO. The firm develops and sells trea...

November 11, 2021, 1:17 pm

Journey medical aims for $35 million ipo

Journey Medical Corporation has filed proposed terms for a $35.2 million IPO. The firm develops and sells trea...

November 11, 2021, 1:17 pm

Journey medical aims for $35 million ipo

Journey Medical Corporation has filed proposed terms for a $35.2 million IPO. The firm develops and sells trea...

November 11, 2021, 1:17 pm


Search within

Pages Search Results: